Myocardial infarction · patients with non‐ST elevation acute coronary syndromes
Heparin may leads to lower incidence of myocardial infarction compared with placebo (low certainty).
1 finding from 1 review
Recurrent angina · patients with non‐ST elevation acute coronary syndromes
It is very uncertain whether heparin changes recurrent angina compared with placebo (very low certainty).
1 finding from 1 review
Incidence of revascularization procedures · patients with non‐ST elevation acute coronary syndromes
Heparin showed no clear difference in incidence of revascularization procedures compared with placebo (low certainty).
1 finding from 1 review
Major hemorrhage · patients with non‐ST elevation acute coronary syndromes
Heparin showed no clear difference in major hemorrhage compared with placebo (low certainty).
1 finding from 1 review
Intervention not reported
Positive serology: RCT data ‐ nitroderivatives Conventional serology, AT and F29 ELISA techniques · people with chronic asymptomatic Trypanosoma cruzi infection
The intervention probably leads to lower positive serology: RCT data ‐ nitroderivatives Conventional… (moderate certainty).
1 finding from 1 review
Intervention not reported
Positive PCR: RCT data ‐ benznidazole‐ Children PCR · people with chronic asymptomatic Trypanosoma cruzi infection
The intervention showed no clear difference in positive PCR: RCT data ‐ benznidazole‐ Children PCR (moderate certainty).
1 finding from 1 review
Intervention not reported
Positive xenodiagnosis: all populations ‐ RCT data ‐ nitroderivatives Xenodiagnosis · people with chronic asymptomatic Trypanosoma cruzi infection
The intervention leads to lower positive xenodiagnosis: all populations ‐ RCT data ‐… (high certainty).
1 finding from 1 review
Intervention not reported
Mean reduction of antibodies titres: all populations, all tested drugs Mean change of antibodies · people with chronic asymptomatic Trypanosoma cruzi infection
1 finding from 1 review
Intervention not reported
ECG Abnormalities ‐ RCT data ‐ benznidazole · people with chronic asymptomatic Trypanosoma cruzi infection
The intervention showed no clear difference in ECG Abnormalities ‐ RCT data ‐ benznidazole (low certainty).
1 finding from 1 review
Intervention not reported
Progression of cardiomyopathy: non‐RCT data ‐ adults ‐ nitroderivatives Emergence of substantial changes in the diagnostic tests or clinical status, or both (see text) · people with chronic asymptomatic Trypanosoma cruzi infection
It is very uncertain whether the intervention changes progression of cardiomyopathy: non‐RCT data ‐ adults ‐… (very low certainty).
1 finding from 1 review
Intervention not reported
Mortality: non‐RCT data ‐ adults ‐ nitroderivatives All‐cause mortality · people with chronic asymptomatic Trypanosoma cruzi infection
It is very uncertain whether the intervention changes mortality: non‐RCT data ‐ adults ‐ nitroderivatives All‐cause… (very low certainty).
1 finding from 1 review
All‐cause mortality · patients with heart failure
1 finding from 1 review
Hospitalization/ rehospitalization · patients with heart failure
1 finding from 1 review
All‐cause mortality · patients with heart failure
1 finding from 1 review
Lack of improvement in heart failure ( NYHA class improved < I class or worsening of heart failure) · patients with heart failure
Shengmai may leads to lower lack of improvement in heart failure (NYHA class improved < I class… compared with placebo (low certainty).
1 finding from 1 review
Adverse effects · patients with heart failure
1 finding from 1 review
no estimate extracted
1 study · 2 participants
GRADE not reported
Change in Exercise test (min) · patients with heart failure
1 finding from 1 review
Change in Ejection fraction (%) · patients with heart failure
1 finding from 1 review
Mean change in cardiac output (L/min) · patients with heart failure
1 finding from 1 review
Change in cardiac index (L/min*m²) · patients with heart failure
1 finding from 1 review